PMID: 7539136May 23, 1995Paper

Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice

Proceedings of the National Academy of Sciences of the United States of America
H HirotaT Taga

Abstract

To investigate the physiological roles of gp130 in detail and to determine the pathological consequence of abnormal activation of gp130, transgenic mice having continuously activated gp130 were created. This was carried out by mating mice from interleukin 6 (IL-6) and IL-6 receptor (IL-6R) transgenic lines. Offspring overexpressing both IL-6 and IL-6R showed constitutive tyrosine phosphorylation of gp130 and a downstream signaling molecule, acute phase response factor/signal transducer and activator of transcription 3. Surprisingly, the distinguishing feature of such offspring was hypertrophy of ventricular myocardium and consequent thickened ventricular walls of the heart, where gp130 is also expressed, in adulthood. Transgenic mice overexpressing either IL-6 or IL-6R alone did not show detectable myocardial abnormalities. Neonatal heart muscle cells from normal mice, when cultured in vitro, enlarged in response to a combination of IL-6 and a soluble form of IL-6R. The results suggest that activation of the gp130 signaling pathways leads to cardiac hypertrophy and that these signals might be involved in physiological regulation of myocardium.

References

Feb 1, 1992·Japanese Circulation Journal·M ShokiH Yasuda
Oct 23, 1992·Science·T KishimotoT Taga
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T TagaT Kishimoto
Jan 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S SuematsuT Kishimoto
May 1, 1991·Journal of Cellular Biochemistry·D J Hilton, N M Gough
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D Metcalf, D P Gearing
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S SuematsuT Kishimoto
May 1, 1969·American Heart Journal·E Bajusz
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·D PennicaK R Chien
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·M NarazakiT Taga
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T TamuraT Taga
Jan 28, 1994·Cell·T KishimotoS Akira

❮ Previous
Next ❯

Citations

Jul 5, 1997·Biotechnology and Bioengineering·C M RothM L Yarmush
Jan 9, 2001·Journal of Cellular Physiology·K HasegawaS Sasayama
May 1, 1997·Protein Science : a Publication of the Protein Society·R J SimpsonL D Ward
Feb 1, 2000·Biochemical and Biophysical Research Communications·T SasaguriJ Ogata
Mar 18, 2000·Biochemical and Biophysical Research Communications·M SanoS Ogawa
Dec 19, 2000·Biochemical and Biophysical Research Communications·S AsaiK Nakao
May 29, 2007·Basic Research in Cardiology·P Fischer, D Hilfiker-Kleiner
Oct 6, 2007·Basic Research in Cardiology·Philipp Fischer, Denise Hilfiker-Kleiner
May 21, 2011·Modern Rheumatology·Shumpei YokotaMasaaki Mori
Mar 25, 2005·Molecular and Cellular Biochemistry·Mazen KurdiGiampiero Bricca
Sep 4, 2008·Current Heart Failure Reports·Mamoru SatohMotoyuki Nakamura
Sep 28, 2012·Journal of Cardiovascular Translational Research·Melissa L Martin, Burns C Blaxall
Oct 1, 1995·Trends in Endocrinology and Metabolism : TEM·A Fukamizu, K Murakami
May 1, 1996·Trends in Cardiovascular Medicine·H HirotaT Kishimoto
Dec 9, 2003·Mechanisms of Ageing and Development·Hiroshi SaitoB Mark Evers
Dec 31, 2003·Trends in Genetics : TIG·Matthias Ernst, Brendan J Jenkins
Nov 14, 2000·The American Journal of Pathology·A G BrunelloJ Weis
Mar 27, 2001·Transplantation Proceedings·E J BirksM H Yacoub
Dec 1, 1996·Immunology Letters·M PetersS Rose-John
Aug 17, 2002·Peptides·Michihisa JougasakiJohn C Burnett
Dec 10, 1999·Journal of the American College of Cardiology·L GullestadM Fowler
Jul 2, 2003·Brain, Behavior, and Immunity·Andreas JeronFrank Muders
Apr 1, 1997·Baillière's Clinical Endocrinology and Metabolism·K W NgD M Findlay
Jun 28, 2000·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·P CorbiJ C Lecron
Apr 15, 2008·Trends in Endocrinology and Metabolism : TEM·B J Wedel, D L Garbers
Feb 6, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Emma J BirksMagdi H Yacoub
Dec 1, 1996·Cytokine & Growth Factor Reviews·D L Mann
Jun 10, 1998·Cytokine & Growth Factor Reviews·T HiranoM Hibi
Oct 27, 2001·Acta Physiologica Scandinavica·Y Takeishi, R A Walsh
Sep 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Salahuddin AhmedAlisa E Koch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

© 2021 Meta ULC. All rights reserved